Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum

Exciting new research led by Dr. Kejal Kantarci, co-leader of the NAPS Neuroimaging Core, at Mayo Clinic.

Her study on FDG-PET brain imaging has uncovered crucial insights into brain metabolism changes during mild cognitive impairment. The findings show a pattern similar to dementia with Lewy bodies and reveal how FDG-PET results can track the progression of symptoms to dementia over time. This study highlights the significance of longitudinal measurements and how they could help develop biomarkers for neurodegenerative diseases.

Read more at the link below.